Finance

Lists
Why is RHHVF up 2,30%?
Dive Deeper
RHHVF:OTCMKTS
Roche Holding AG Genussscheine
448,14 $
+2,30%
(+10,08) 1D
14 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RHHVF...
Open
446,60 $
High
448,14 $
Low
439,76 $
Mkt. cap
362,68 մլրդ
Avg. vol.
4,71 հզր
Volume
133,00
52-wk high
490,33 $
52-wk low
318,81 $
Beta
0,51
Shares outstanding
702,56 մլն
No. of employees
113 հզր
Open
446,60 $
High
448,14 $
Low
439,76 $
Mkt. cap
362,68 մլրդ
Avg. vol.
4,71 հզր
Volume
133,00
52-wk high
490,33 $
52-wk low
318,81 $
Beta
0,51
Shares outstanding
702,56 մլն
No. of employees
113 հզր
News stories
From web sources and news partners
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in the Forbes Global 2000 was 76. The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees113 հզր
Founded01 հոկ, 1896 թ.
HeadquartersԲասել, Basel City, Շվեյցարիա
Sector-
Websiteroche.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
15,75 մլրդ
15,75 մլրդ
15,73 մլրդ
15,73 մլրդ
Cost of goods sold
4,21 մլրդ
4,21 մլրդ
3,93 մլրդ
3,93 մլրդ
Cost of revenue
4,21 մլրդ
4,21 մլրդ
3,93 մլրդ
3,93 մլրդ
Research and development expenses
3,15 մլրդ
3,15 մլրդ
2,99 մլրդ
2,99 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,59 մլրդ
3,59 մլրդ
3,22 մլրդ
3,22 մլրդ
Operating expense
6,82 մլրդ
6,82 մլրդ
6,11 մլրդ
6,11 մլրդ
Total operating expenses
11,03 մլրդ
11,03 մլրդ
10,03 մլրդ
10,03 մլրդ
Operating income
4,72 մլրդ
4,72 մլրդ
5,69 մլրդ
5,69 մլրդ
Other non operating income
-10,00 մլն
-10,00 մլն
-15,00 մլն
-15,00 մլն
EBT including unusual items
3,69 մլրդ
3,69 մլրդ
4,49 մլրդ
4,49 մլրդ
EBT excluding unusual items
4,37 մլրդ
4,37 մլրդ
5,38 մլրդ
5,38 մլրդ
Income tax expense
709,00 մլն
709,00 մլն
824,00 մլն
824,00 մլն
Effective tax rate
19,20%
19,20%
18,37%
18,37%
Other operating expenses
77,50 մլն
77,50 մլն
-99,00 մլն
-99,00 մլն
Net income
2,74 մլրդ
2,74 մլրդ
3,44 մլրդ
3,44 մլրդ
Net profit margin
17,36%
17,36%
21,85%
21,85%
Earnings per share
-
-
-
-
Interest and investment income
45,00 մլն
45,00 մլն
43,50 մլն
43,50 մլն
Interest expense
-289,50 մլն
-289,50 մլն
-282,00 մլն
-282,00 մլն
Net interest expenses
-244,50 մլն
-244,50 մլն
-238,50 մլն
-238,50 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
5,50 մլրդ
5,50 մլրդ
6,48 մլրդ
6,48 մլրդ
Gain or loss from assets sale
-21,50 մլն
-21,50 մլն
-2,50 մլն
-2,50 մլն
AI content may include mistakes. Learn more
Google Apps